Effective lock-in strategy for proteomic analysis of corona complexes bound to amino-free ligands of gold nanoparticles.

For specific applications, gold nanoparticles (GNPs) are commonly functionalized with various biological ligands, including amino-free ligands such as amino acids, peptides, proteins, and nucleic acids. Upon entering a biological fluid, the protein corona that forms around GNPs can conceal the targeting ligands and sterically hinder the functional properties. The protein corona is routinely prepared by standard centrifugation or sucrose cushion centrifugation. However, such methodologies are not applicable to the exclusive analysis of a ligand-binding protein corona. In this study, we first proposed a lock-in strategy based on a combination of rapid crosslinking and stringent washing. Cysteine was used as a model of amino-free ligands and attached to GNPs. After corona formation in the human plasma, GNP cysteine and corona proteins were quickly fixed by 5 s of crosslinking with 7.5% formaldehyde. After stringent washing using SDS buffer with sonication, the cysteine-bound proteins were effectively separated from unbound proteins. Qualitative and quantitative analyses using a mass spectrometry-based proteomics approach indicated that the protein composition of the cysteine-binding corona from the new method was significantly different from the composition of the whole corona from the two conventional methods. Furthermore, network and formaldehyde-linked site analyses of cysteine-binding proteins provided useful information toward a better knowledge of the behavior of protein-ligand and protein-protein interactions. Collectively, our new strategy has the capability to particularly characterize the protein composition of a cysteine-binding corona. The presented methodology in principal provides a generic way to analyze a nanoparticle corona bound to amino-free ligands and has the potential to decipher corona-masked ligand functions.

[1]  David Tai Leong,et al.  Antimicrobial silver nanomaterials , 2018 .

[2]  Mukesh Roy,et al.  l-Cysteine-Conjugated Ruthenium Hydrous Oxide Nanomaterials with Anticancer Active Application. , 2018, Langmuir : the ACS journal of surfaces and colloids.

[3]  Wolfgang J Parak,et al.  A Decade of the Protein Corona. , 2017, ACS nano.

[4]  M. Kołaczkowski,et al.  Novel and effective synthesis protocol of AgNPs functionalized using L-cysteine as a potential drug carrier , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  P. Xie,et al.  Proteomic and network analysis of human serum albuminome by integrated use of quick crosslinking and two-step precipitation , 2017, Scientific Reports.

[6]  Jianping Xie,et al.  Engineering gold-based radiosensitizers for cancer radiotherapy , 2017 .

[7]  U. Simon,et al.  The effects of gold nanoparticles functionalized with ß-amyloid specific peptides on an in vitro model of blood-brain barrier. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[8]  Jian Zhou,et al.  In-depth analysis of the synaptic plasma membrane proteome of small hippocampal slices using an integrated approach , 2017, Neuroscience.

[9]  M. I. Setyawati,et al.  Antimicrobial Gold Nanoclusters. , 2017, ACS nano.

[10]  I. Prior,et al.  Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation. , 2017, Nanoscale.

[11]  Beom-Jin Lee,et al.  Protein corona: a new approach for nanomedicine design , 2017, International journal of nanomedicine.

[12]  Biqiong Chen,et al.  Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity. , 2017, Small.

[13]  P. Xie,et al.  Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion , 2016, PloS one.

[14]  H. -. Kim,et al.  Tailoring the Electronic and Catalytic Properties of Au25 Nanoclusters via Ligand Engineering. , 2016, ACS nano.

[15]  Alaaldin M. Alkilany,et al.  Protein corona: Opportunities and challenges. , 2016, The international journal of biochemistry & cell biology.

[16]  Raehyun Kim,et al.  The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. , 2016, The international journal of biochemistry & cell biology.

[17]  Yu Cheng,et al.  Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer. , 2016, Molecular pharmaceutics.

[18]  M. Tinti,et al.  Global Membrane Protein Interactome Analysis using In vivo Crosslinking and Mass Spectrometry-based Protein Correlation Profiling* , 2016, Molecular & Cellular Proteomics.

[19]  R. Barker,et al.  Characterization and Visualization of Vesicles in the Endo-Lysosomal Pathway with Surface-Enhanced Raman Spectroscopy and Chemometrics. , 2016, ACS nano.

[20]  Xuan Ding,et al.  Formaldehyde cross-linking and structural proteomics: Bridging the gap. , 2015, Methods.

[21]  Zhen Liu,et al.  Development and application of wide-range gradient gel electrophoresis to proteome analysis , 2015 .

[22]  P. Xie,et al.  Quantitative Proteomic Analysis Reveals Molecular Adaptations in the Hippocampal Synaptic Active Zone of Chronic Mild Stress-Unsusceptible Rats , 2015, The international journal of neuropsychopharmacology.

[23]  Brian L. Frey,et al.  Formaldehyde Crosslinking: A Tool for the Study of Chromatin Complexes* , 2015, The Journal of Biological Chemistry.

[24]  J. Bettmer,et al.  Complementary mass spectrometric techniques for the quantification of the protein corona: a case study on gold nanoparticles and human serum proteins. , 2015, Nanoscale.

[25]  R. Stauber,et al.  The nanoparticle biomolecule corona: lessons learned - challenge accepted? , 2015, Chemical Society reviews.

[26]  E. Giralt,et al.  Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches , 2015, International journal of nanomedicine.

[27]  Manzhou Zhu,et al.  One-phase controlled synthesis of Au25 nanospheres and nanorods from 1.3 nm Au : PPh3 nanoparticles: the ligand effects. , 2015, Nanoscale.

[28]  U. Häfeli,et al.  Utilization of nanoparticles as X-ray contrast agents for diagnostic imaging applications. , 2015, Contrast media & molecular imaging.

[29]  R. Jin,et al.  Chemoselective Hydrogenation of Nitrobenzaldehyde to Nitrobenzyl Alcohol with Unsupported Au Nanorod Catalysts in Water , 2015 .

[30]  M. E. Kenney,et al.  Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. , 2015, Nanoscale.

[31]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[32]  Hanfa Zou,et al.  Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. , 2014, Colloids and surfaces. B, Biointerfaces.

[33]  Stefan Tenzer,et al.  Quantitative profiling of the protein coronas that form around nanoparticles , 2014, Nature Protocols.

[34]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[35]  Youhe Gao,et al.  Fast fixing and comprehensive identification to help improve real-time ligands discovery based on formaldehyde crosslinking, immunoprecipitation and SDS-PAGE separation , 2014, Proteome Science.

[36]  Robert Dominko,et al.  Preparation, structure and electrochemistry of LiFeBO3: a cathode material for Li-ion batteries , 2014 .

[37]  Chad A. Mirkin,et al.  Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma , 2013, Science Translational Medicine.

[38]  R. Shukla,et al.  Fine-Tuning the Antimicrobial Profile of Biocompatible Gold Nanoparticles by Sequential Surface Functionalization Using Polyoxometalates and Lysine , 2013, PloS one.

[39]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[40]  J. Berlin,et al.  Gold Nanoparticle‐Loaded Neural Stem Cells for Photothermal Ablation of Cancer , 2013, Advanced healthcare materials.

[41]  Chengtie Wu,et al.  Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration , 2013, International journal of nanomedicine.

[42]  Jianjun Cheng,et al.  Protein corona significantly reduces active targeting yield. , 2013, Chemical communications.

[43]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[44]  Ping Yu,et al.  Aspartic acid-promoted highly selective and sensitive colorimetric sensing of cysteine in rat brain. , 2012, Analytical chemistry.

[45]  K. Hynynen,et al.  Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[46]  D. B. Hibbert,et al.  Measurement of gold and sulfur mass fractions in L-cysteine-modified gold nanoparticles by ICP-DRC-MS after acid digestion: validation and uncertainty of results , 2012 .

[47]  J. Kast,et al.  Advancing formaldehyde cross-linking towards quantitative proteomic applications , 2012, Analytical and Bioanalytical Chemistry.

[48]  Quanze He,et al.  Electrophoretically driven SDS removal and protein fractionation in the shotgun analysis of membrane proteomes , 2012, Electrophoresis.

[49]  Giulio Caracciolo,et al.  Evolution of the protein corona of lipid gene vectors as a function of plasma concentration. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[50]  P. Xie,et al.  Preparation and application of a partially degradable gel in mass spectrometry-based proteomic analysis. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[51]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[52]  S. Tenzer,et al.  Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.

[53]  S. Singh,et al.  Functionalized Gold Nanoparticles and Their Biomedical Applications , 2011, Nanomaterials.

[54]  Ping Chen,et al.  Dried polyacrylamide gel absorption: A method for efficient elimination of the interferences from SDS‐solubilized protein samples in mass spectrometry‐based proteome analysis , 2010, Electrophoresis.

[55]  Steven A. Curley,et al.  Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles , 2010, Clinical Cancer Research.

[56]  Juergen Kast,et al.  Optimization of Formaldehyde Cross-Linking for Protein Interaction Analysis of Non-Tagged Integrin β1 , 2010, Journal of biomedicine & biotechnology.

[57]  D. Maysinger,et al.  Microglial response to gold nanoparticles. , 2010, ACS nano.

[58]  D. Astruc,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[59]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[60]  J. Kast,et al.  Utility of formaldehyde cross-linking and mass spectrometry in the study of protein-protein interactions. , 2008, Journal of mass spectrometry : JMS.

[61]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[62]  Andrea Sinz,et al.  Chemical cross-linking and mass spectrometry to map three-dimensional protein structures and protein-protein interactions. , 2006, Mass spectrometry reviews.

[63]  Enzo Terreno,et al.  The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.

[64]  W. Hennink,et al.  Identification of Formaldehyde-induced Modifications in Proteins , 2004, Journal of Biological Chemistry.

[65]  Gary D Bader,et al.  BMC Bioinformatics Methodology article Statistical significance for hierarchical clustering in genetic association and microarray expression studies , 2003 .

[66]  M. Biggin,et al.  The specificity of protein-DNA crosslinking by formaldehyde: in vitro and in drosophila embryos. , 2000, Nucleic acids research.

[67]  Hoeil Chung,et al.  Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133. , 2017, Acta biomaterialia.

[68]  M. Mahmoudi,et al.  Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. , 2016, Biomaterials.

[69]  Francesco Salvatore,et al.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.

[70]  T. Meade,et al.  DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells. , 2016, Biomaterials.

[71]  Sarah Hurst Petrosko,et al.  Therapeutic applications of spherical nucleic acids. , 2015, Cancer treatment and research.

[72]  Liyi Shi,et al.  Cysteine modified rare-earth up-converting nanoparticles for in vitro and in vivo bioimaging. , 2014, Biomaterials.

[73]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.